Nutrastars revenue & earnings fell short for 2013 with fully diluted eps of $1.30 when I expected $1.40 on less revenue than the company gave guidance for.
International introduction of new products they have been working on pushed back to 2015 & introduction of health drinks is proceeding very slowly making 2014 revenue guidance $47-$50M instead of the $55M+ I was also expecting.
With over $100M in cash I see no need to conserve cash unless a acquisition is planned in the near future.
This effects my near term target of $5.50 as well as my 2014 target of $8.50 while 2015 still looks bright if indeed the developed pills are ready for international introduction then as planned.
I am changing my opinion on Nutrastar to hold unless a acquisition or dividend are forth coming this year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.